Americhem, a global leader in custom polymer solutions, opens a new clean compounding facility in Suzhou (China) on September 28. The investment expands Americhem’s ability to support customers in China, across Asia-Pacific, and around the world who manufacture in the region.

The opening ceremony of Americhem’s new clean compounding facility on September 28.

“This investment reflects our commitment to global continuity, regional responsiveness, and the quality standards our healthcare customers rely on,” said John Richard, CEO at Americhem.

Designed to meet ISO 13485 and cGMP requirements for demanding medical device applications, the facility expands Americhem’s global clean compounding network alongside its existing certified capabilities in the United States and Denmark.

It brings reliable production, consistent quality, and technical support closer to healthcare OEMs to develop and manufacture highly regulated products.

“The Suzhou facility allows us to collaborate more closely with customers in China and support the same quality, reliability, and service they expect from Americhem worldwide,” said Rose Tu, Vice President of APAC at Americhem.

Supporting healthcare innovation

Healthcare is a leading growth market for Americhem, driven by demand for biocompatible, sterilization-durable, traceable, and regulatory-ready materials.

Americhem solutions are used in self-care and home healthcare devices, glucose monitors, surgical instruments, and components for robotic-assisted surgery.

Its clean compounding network supports customers from material selection and prototyping through qualification, commercialization, and regional scale-up, with consistent support across manufacturing locations.